Downregulating Notch counteracts Kras(G12D)-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.
Downregulating Notch counteracts Kras(G12D)-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.
复制标题
下调Notch可抵消Kras(G12D)诱导的骨髓增殖性肿瘤中的ERK激活和氧化磷酸化。
DOI:
10.1038/s41375-018-0248-0
复制
发表时间:
2019-03
期刊:
影响因子:
11.4
通讯作者:
Zhang J
中科院分区:
文献类型:
--
作者:
Kong G;You X;Wen Z;Chang YI;Qian S;Ranheim EA;Letson C;Zhang X;Zhou Y;Liu Y;Rajagopalan A;Zhang J;Stieglitz E;Loh M;Hofmann I;Yang D;Zhong X;Padron E;Zhou L;Pear WS;Zhang J
The Notch signaling pathway contributes to the pathogenesis of a wide spectrum of human cancers, including hematopoietic malignancies. Its functions are highly dependent on the specific cellular context. Gain-of-function NOTCH1 mutations are prevalent in human T cell leukemia, while loss of Notch signaling is reported in myeloid leukemias. Here, we report a novel oncogenic function of Notch signaling in oncogenic Kras-induced myeloproliferative neoplasm (MPN). We find that downregulation of Notch signaling in hematopoietic cells via DNMAML expression or Pofut1 deletion significantly blocks MPN development in KrasG12D mice in a cell-autonomous manner. Further mechanistic studies indicate that inhibition of Notch signaling significantly upregulates Dusp1, a dual phosphatase that inactivates p-ERK, and downregulates cytokine-evoked ERK activation in KrasG12D cells. Moreover, mitochondrial metabolism is greatly enhanced in KrasG12D cells but significantly reprogrammed by DNMAML close to that in control cells. Consequently, cell proliferation and expanded myeloid compartment in KrasG12D mice are significantly reduced. Consistent with these findings, combined inhibition of the MEK/ERK pathway and mitochondrial oxidative phosphorylation effectively inhibited the growth of human and mouse leukemia cells in vitro. Our study provides a strong rational to target both ERK signaling and aberrant metabolism in oncogenic Ras-driven myeloid leukemia.
登录
查看更多内容
影响因子:
23.9
作者:
Lagadinou, Eleni D.;Sach, Alexander;Callahan, Kevin;Rossi, Randall M.;Neering, Sarah J.;Minhajuddin, Mohammad;Ashton, John M.;Pei, Shanshan;Grose, Valerie;O'Dwyer, Kristen M.;Liesveld, Jane L.;Brookes, Paul S.;Becker, Michael W.;Jordan, Craig T.
通讯作者:
Jordan, Craig T.
DOI:
10.1084/jem.20121484
发表时间:
2013-02-11
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Lobry C;Ntziachristos P;Ndiaye-Lobry D;Oh P;Cimmino L;Zhu N;Araldi E;Hu W;Freund J;Abdel-Wahab O;Ibrahim S;Skokos D;Armstrong SA;Levine RL;Park CY;Aifantis I
通讯作者:
Aifantis I
影响因子:
3
作者:
Clausen, BE;Burkhardt, C;Förster, I
通讯作者:
Förster, I
影响因子:
5.3
作者:
KIDD, S;KELLEY, MR;YOUNG, MW
通讯作者:
YOUNG, MW
DOI:
10.1084/jem.20121527
发表时间:
2013-02-11
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kannan S;Sutphin RM;Hall MG;Golfman LS;Fang W;Nolo RM;Akers LJ;Hammitt RA;McMurray JS;Kornblau SM;Melnick AM;Figueroa ME;Zweidler-McKay PA
通讯作者:
Zweidler-McKay PA